Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 880-881

  Kurtaran, Amir ^a   Raderer, Markus ^a   Müller, Christian ^a   Prokesch, Rupert ^a   Kaserer, Klaus ^a   Eibenberger, Klemens ^a   Koperna, Katharina ^a   Niederle, Bruno ^a   Virgolini, Irene ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hemangioma; Indium 111 DTPA D Phe 1 octreotide; Iodine 123 vasoactive intestinal peptide; Liver carcinoid metastasis

Indexed keywords

IODINE 123; PENTETATE INDIUM IN 111; SOMATOSTATIN RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

AGED; ARTICLE; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER SCINTISCANNING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARCINOID TUMOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOMA; HUMANS; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030948604     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bennett WF, Bowa JG. Review of hepatic imaging and problem-oriented approach to liver masses. Hepatology 1990;12:761-775.
2. Andersson T, Eriksson B, Hemmingsson A, Lindgren PG, Öberg K. Angiography, computed tomography, magnetic resonance imaging and ultrasonography in the detection of liver metastases from endocrine gastrointestinal tumors. Acta Radiology 1987;5:535-539.
3. Reinhold C, Hammers L, Taylor CR, et al. Characterization of focal hepatic lesions with duplex sonography. Am J Roentgenol 1995;164:1131-1135.
4. Rummeny E, Saini S, Wittenberg J, et al. MR imaging of liver neoplasms. Am J Roentgenol 1989;152:493-499.
5. King CL, Glazer GM, Quint LE, et al. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology 1988;169:409-415.
6. Kwekkeboom DJ, Krenning EP, Bakker WH, et al. Somatostatin analogue scintigraphy in carcinoid tumors. Ear J Nucl Med 1993;20:283-292.
7. Virgolini I, Raderer M, Kurtaran A, et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 1994;331:1116-1121.
8. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995-998.
9. Lombarde DM, Baker ME, Spritzer CE, et al. Hepatic hemangiomas versus metastases: MR differentiation at 1.5 T. Am J Roenlgenol 1990;153:55-59.
10. 99mTc-labeled red cells and SPECT. Am J Roentgenol 1987;148:125-129.
11. Tuineh SS, Benson C, Nagel JS, et al. Cavernous hemangioma of the liver: detection with single-photon emission computed tomography. Radiology 1987; 164:353-356.
12. Leslie DF, Johnson CD, Johnson CM, et al. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. Am J Roenlgenol 1995;164:625-629.
13. Stark DD, Felder RC, Wittenberg J, et al. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. Am J Roentgenol 1985;145: 213-222.
14. Itai Y, Ohtomo K, Furui S, et al. Noninvasive diagnosis of small cavernous hemangioma of the liver: advantage of MRI. Am J Roenlgenol 1985;145:1195-1199.
15. Li KC, Glazer GM, Leslie EQ, et al. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology 1988;169:409-415.